Patent foramen ovale. What is it and what does' it indicate?;Foramen oval permeable: ¿Cómo y de qué es factor de riesgo?

Neurologia

Volumn 21, Issue 10, 2006, Pages 689-694

  Serena, Joaquín ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Echocardiography; Foramen ovale; Stroke; Transcranial doppler

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5;

CLINICAL TRIAL; DOPPLER ECHOGRAPHY; HEART ATRIUM SEPTUM DEFECT; HUMAN; META ANALYSIS; RECURRENT DISEASE; REVIEW; RISK FACTOR; STROKE; SYSTEMATIC REVIEW; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; CEREBROVASCULAR ACCIDENT; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MIDDLE AGED; RECURRENCE; RISK FACTORS;

EID: 33845962233     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989;25:382-90.
2. Lechat PH, Mas JL, Lascault G, Loron PH, Theard M, Klimczac M, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-52.
3. Webster MW, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM, et al. Patent foramen ovale in young stroke patients. Lancet 1988;2:11-2.
4. Belvis R, Leta RG, Marti-Fabregas J, Cocho D, Carreras F, Pons-Llado G, et al. Almost perfect concordance between simultaneous transcranial doppler and transesophageal echocardiography in the quantification of right-to-left shunts. J Neuroimaging 2006; 16:133-8.
5. Serena J, Segura T, Pérez-Ayuso MJ, Bassaganyas J, Molins A, Davalos A. The need to quantify right-to-left shunt in acute ischemic stroke: a case-control study. Stroke 1998;29:1322-8.
6. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000; 55:1172-9.
7. Meissner I, Khandheria BK, Heit JA, Petty GW, Sheps SG, Schwartz GL, et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol 2006;47:440-5.
8. Berthet K, Lavergne T, Cohen A, Guize L, Bousser MG, Le Heuzey JY, et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 2000;31:398-403.
9. Srivastava TN, Payment MF. Images in clinical medicine. Paradoxical embolism-thrombus in transit through a patent foramen ovale. N Engl J Med 1997;337:681.
10. Cramer SC, Rordorf G, Maki JH, Kramer LA, Grotta JC, Burgin WS, et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke 2004;35:46-50.
11. Sacco RL, Homma S, Di Tullio MR. Patent foramen ovale: a new risk factor for ischemic stroke. Heart Dis Stroke 1993;2:235-41.
12. Pezzini A, Del Zotto E, Magoni M, Costa A, Archetti S, Grassi M, et al. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke 2003;34: 28-33.
13. Carod-Artal FJ, Vilela S, Portugal D. Trombofilia y foramen en pacientes jóvenes afectos de ictus isquémico. Neurología 2006; 21:710-6.
14. Belvís R, Masjuan J, García-Barragán N, Cocho D, Martí-Fàbregas J, Santamaría A, et al. Stroke and pulmonary thromboembolism after a long flight. Eur J Neurol 2005;12:1-3.
15. Scurr JH, Machin SJ, Bailey-King S, Mackie IJ, McDonald S, Smith PD. Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial. Lancet 2001; 357:1485-9.
16. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Neurology 1996;46:1301-5.
17. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes I, Derumeaux G, et al, for the Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-6.
18. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002;105:2625-31.
19. Kizer JR, Devereux RB. Clinical practice. Patent foramen ovale in young adults with unexplained stroke. N Engl J Med 2005; 353:2361-72.
20. Serena J, Bravo Y, Santamarina E, Segura T, Rodríguez Uranga JJ, Masjuan J, et al., for the investigator of CODICIA Study on behalf of the Stroke Project of the Spanish Cerebrovascular Diseases Study Group. Recurrent stroke is not associated with massive Right-to-Left Shunt: preliminary results from the 3-year prospective Spanish multicentre study. Cerebrovasc Dis 2006; 21(Suppl. 4):1(abstract).
21. Orgera MA, O'Malley PG, Taylor AJ. Secondary prevention of cerebral ischemia in patent foramen ovale: systematic review and meta-analysis. South Med J 2001;94:699-703.
22. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 2003;139:753-60.
23. Messe SR, Silverman IE, Kizer JR, Homma S, Zahn C, Gronseth G, et al., Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004;62:1042-50.
24. Han YM, Gu X, Titus JL, Rickers C, Bass JL, Urness M, et al. New self-expanding patent foramen ovale occlusion device. Catheter Cardiovasc Interv 1999;47:370-6.
25. Cenni E, Ciapetti G, Cervellati M, Cavedagna D, Falsone G, Gamberini S, et al. Activation of the plasma coagulation system induced by some biomaterials. J Biomed Mater Res 1996;31: 145-8.
26. Hong J, Azens A, Ekdahl KN, Granqvist CG, Nilsson B. Material-specific thrombin generation following contact between metal surfaces and whole blood. Biomaterials 2005;26:1397-403.
27. Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004;44:750-8.
28. Wahl A, Meier B, Haxel B, Nedeltchev K, Arnold M, Eicher E, et al. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology 2001;57:1330-2.
29. Anzola GP, Morandi E, Casilli F, Onorato E. Does transcatheter closure of patent foramen ovale really «shut the door»? A prospective study with transcranial doppler. Stroke 2004;35: 2140-4.
30. De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000;31:2407-13.